Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 21:12:05014.
doi: 10.7189/jogh.12.05014.

Symptoms and signs of long COVID: A rapid review and meta-analysis

Affiliations
Review

Symptoms and signs of long COVID: A rapid review and meta-analysis

Quin Healey et al. J Glob Health. .

Abstract

Background: Long COVID is defined as symptoms and signs related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are present at least four weeks following acute infection. These symptoms and signs are poorly characterised but may be associated with significant morbidity. We sought to synthesise the evidence on their incidence to guide future research, policy and practice.

Methods: We searched Medline and Embase for longitudinal cohort studies from January 2020 to July 2021 that investigated adults with long COVID at least four weeks after acute infection. Risk of bias was assessed using the Joanna Briggs Institute checklist for cohort studies. Random-effects meta-analyses were performed with subgroup analysis by follow-up time (4-12 vs more than 12 weeks).

Results: 19 studies were included, 13 of which included patients hospitalised with COVID-19. The total sample size was 10 643 and the follow-up time ranged from 30 to 340 days. Risk of bias was assessed as high in one study, moderate in two studies and low in the remaining 16 studies. The most common symptoms and signs seen at any time point in long COVID were fatigue (37%; 95% confidence interval (CI) = 23-55), dyspnoea (21%; 95% CI = 14-30), olfactory dysfunction (17%; 95% CI = 9-29), myalgia (12%; 95% CI = 5-25), cough (11%; 95% CI = 6-20) and gustatory dysfunction (10%; 95% CI = 7-17). High heterogeneity was seen for all meta-analyses and the presence of some funnel plot asymmetry may indicate reporting bias. No effect of follow-up time was found for any symptom or sign included in the subgroup analysis.

Conclusions: We have summarised evidence from longitudinal cohort studies on the most common symptoms and signs associated with long COVID. High heterogeneity seen in the meta-analysis means pooled incidence estimates should be interpreted with caution. This heterogeneity may be attributable to studies including patients from different health care settings and countries.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors completed the ICMJE Unified Competing Interest Form (available upon request from the corresponding author) and declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flowchart of the study selection process.
Figure 2
Figure 2
Meta-analysis of symptoms reported by at least five studies.

References

    1. National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NICE guideline 188). 2021. Available: https://www.nice.org.uk/guidance/ng188. Accessed: 24 January 2022.
    1. Kingstone T, Taylor AK, O'Donnell CA, Atherton H, Blane DN, Chew-Graham CA.Finding the 'right' GP: a qualitative study of the experiences of people with long-COVID. BJGP Open. 2020;4:bjgpopen20X101143. 10.3399/bjgpopen20X101143 - DOI - PMC - PubMed
    1. Cucinotta D, Vanelli M.WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157. - PMC - PubMed
    1. World Health Organisation. COVID-19 Dashboard. Available: https://covid19.who.int/. Accessed: 24 January 2022.
    1. Glasper A.How the UK plans to tackle long COVID. Br J Healthc Assist. 2021;15:402-6. 10.12968/bjha.2021.15.8.402 - DOI